The Patent Finder

Merck Serono S.A.

Also on record
Records under this name other than the patents Merck Serono S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 31 patents it holds.

Back to Merck Serono S.A.

PatentTitleStatus Expires Confidence
US 10,555,934Alpha-Amino Esters of Hydroxypropylthiazolidine Carboxamide Derivative and Salt Form, Crystal Polymorph Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,524,003Alpha-Amino Esters of Hydroxypropylthiazolidine Carboxamide Derivative and Salt Form, Crystal Polymorph Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,566,062Methods for modulating protein mannosylation profiles using maduramycin, narasin, or salinomycin
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,878,967Novel Crystalline Forms of 1-(4-{[6-Amino-5-(4-Phenoxy-PHENYL)-PYRIMIDIN-4-Ylamino]-METHYL}-4-Fluoro-PIPERIDIN-1-YL)-PROPENONE, Salt Forms Thereof, and Processes to Obtain
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,713,947Cladribine Regimen for Treating Multiple Sclerosis
Term ended
Term ended Oct 16, 2026 · High confidence
Term endedTerm ended Oct 16, 2026High confidence
US 7,951,359Compositions and Methods for Therapy or Prevention of Chemotherapy-Induced Neuropathy
Term ended
Term ended Sep 28, 2026 · High confidence
Term endedTerm ended Sep 28, 2026High confidence
US 8,802,703Novel Arylamino N-Heteraryl Compounds as Mek Inhibitors
Lapsed on the fee record
Ended Aug 12, 2026 · High confidence
Lapsed on the fee recordEnded Aug 12, 2026High confidence
US 8,128,920Use of IL-18BP isoforms for the treatment and/or prevention of neurological inflammatory diseases
Term ended
Term ended Jun 2, 2026 · From the USPTO record
Term endedTerm ended Jun 2, 2026From the USPTO record
US 8,377,903Cladribine Regimen for Treating Multiple Sclerosis
Term ended
Term ended May 31, 2026 · Low confidence
Term endedTerm ended May 31, 2026Low confidence
US 7,824,907Expression vectors comprising the mCMV IE2 promoter
Term ended
Term ended May 30, 2026 · From the USPTO record
Term endedTerm ended May 30, 2026From the USPTO record
10 of 278 patents shown.
Pro members see all 278.
Pro members: see all 278 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited